https://www.avient.com/investor-center/news/avient-signs-agreement-divest-distribution-business-hig-capital-950-million
based on the strength of their proposal, which values the business at approximately 10x LTM EBITDA and includes no financing contingencies. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
https://www.avient.com/industries/healthcare/drug-delivery-systems/prefilled-syringes
Mevopur™ Healthcare Bio-based Polymer Solutions Drop-in colorants and additives based on bio-polymers for the regulated healthcare market
https://www.avient.com/investor-center/news/avient-announces-commencement-650-million-senior-notes-offering
They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; disruptions or inefficiencies in our supply chain, logistics, or operations; changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; fluctuations in raw material prices, quality and supply, and in energy prices and supply; demand for our products and services; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA; other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, and any recessionary conditions; and other factors described in our Annual Report on Form 10-K for the year ended
https://www.avient.com/industries/healthcare/catheter-materials-medical-tubing/medical-tubing
Traditional and bio-based thermoplastic elastomers (TPEs) formulated specifically to handle the complexities of biopharma tubing (BT) Mevopur™ Healthcare Bio-based Polymer Solutions
https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/edgetek-pke-polyketone-formulations
Helping to improve sustainability over the end-product lifecycle, these formulations offer a reduced carbon footprint as a result of the PK base resin. Electrical and electronic components, including mini circuit breaker (MCB) mechanisms and molded case circuit breaker (MCCB) bases
https://www.avient.com/company/policies-and-governance/colormatrix-europe-limited-modern-slavery-and-human-trafficking-statement-0
The Avient ethics hotline is available globally to make a web-based or telephonic report, with multi-language capabilities, 24 hours a day, seven days a week. Our supply base currently includes 63 suppliers: 70% located in the UK, 17% in the EU and the remaining 13% split between China, USA and India.
https://www.avient.com/company/policies-and-governance
At Avient, we strive to conduct our business activities in a manner that is protective of health and the environment, while using a scientific and risk-based approach to chemical management. Without the dedication of our supplier base, Avient would not be able to achieve customer satisfaction, deliver conforming products or maintain our internal Quality Policy.
https://www.avient.com/products/polymer-additives
Mevopur™ Healthcare Bio-based Polymer Solutions Mevopur™ Healthcare Bio-based Polymer Solutions
https://www.avient.com/knowledge-base/article/developing-your-esg-framework
Measuring performance based on ESG metrics can help your organization and its various stakeholders develop trust and unity on sustainability goals. We typically analyze raw material suppliers through EcoVadis – who evaluates an organization based off 21 different sustainability topics that are categorized into environment, labor and human rights, ethics, and sustainable procurement.
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2024-results
supported by broad-based growth across all regions and most end markets operating results due to the potential variability across periods based on timing, frequency and magnitude. Share-based compensation expense